DAXOR CORPORATION REVISES 2017 DIVIDEND

New York, NY, Dec. 28, 2017 (GLOBE NEWSWIRE) -- Daxor Corporation, (NYSE MKT: DXR) an investment company with medical instrumentation and biotechnology operations, revises the record date and payment date of its 2017 dividend.  The Board of Directors has reaffirmed the annual dividend payment of $0.03 per share. This dividend will be paid on Friday, January 12, 2018 to Daxor shareholders of record on Monday January 8, 2018. The change in dates is procedural to comply with regulatory reporting requirements.

Daxor Corporation manufactures and markets the BVA-100 Blood Volume Analyzer, which is used in conjunction with Volumex, Daxor’s single-use diagnostic kit.  For more information regarding blood volume analysis and the Daxor BVA-100, visit Daxor’s website at www.Daxor.com.

Daxor contact information:

Michael Feldschuh, President and CEO,
212-330-8505,
[email protected]

John Wilkens, Chief Financial Officer,
212-330-8504,
[email protected].

You May Also Be Interested In

• Daxor Corporation Receives U.S. Patent for Breakthrough Remote Blood Volume Monitor
• Hyperliquid $HYPE Breakout Fuels $77 Target Talk as MemeToro Expands Its AI Trading Infrastructure
• Million Securities: Long-Term Potential and Shared Interests